STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

Clinical trial NCT03548935 · COMPLETED

Trial details

NCT number: NCT03548935
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metabolism and Nutrition Disorder Overweight or Obesity

Start date: 2018-06-04
Primary completion: 2020-03-30
Enrollment: 1961

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.